European Renal Association

Recent studies reveal belimumab's effectiveness in treating lupus nephritis, showing significant renal response and improved patient outcomes in real-world settings.

Sayna Norouzi, MD, reflects on the recent progress in the therapeutic pipeline for lupus nephritis.

Sayna Norouzi, MD, discusses results from a pair of trials examining QoL in patients with lupus from ERA 2025.

New analysis reveals obinutuzumab's potential to improve kidney inflammation and biomarkers in lupus nephritis.